Verified peer comparison
Aktis Oncology vs Ebang International Holdings Financial Comparison
Direct answer
Aktis Oncology and Ebang International Holdings are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Aktis Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Aktis Oncology Revenue
- 6,497,000 USD
- Ebang International Holdings Revenue
- 6,536,987 USD
- Aktis Oncology Operating income
- -74,684,000 USD
- Ebang International Holdings Operating income
- -22,836,115 USD